Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Rani Therapeutics Holdings, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q1 2022
- Shares held
- 2.83M
- +268.2K (+10.5%) vs. Q1 2022
- Total value
- $29.1M
- −$5.42M (−15.7%) vs. Q1 2022
- New holders
- 4
- 9 more added
- Sold out
- 0
- 6 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RANI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 68 | $34.7M |
| Q1 2026 | 74 | $31.4M |
| Q4 2025 | 64 | $60.5M |
| Q3 2025 | 38 | $2.02M |
| Q2 2025 | 39 | $3.32M |
| Q1 2025 | 38 | $4.58M |
| Q4 2024 | 42 | $5.23M |
| Q3 2024 | 31 | $12.8M |
| Q2 2024 | 34 | $11.8M |
| Q1 2024 | 37 | $10.7M |
| Q4 2023 | 34 | $10.9M |
| Q3 2023 | 34 | $6.96M |
| Q2 2023 | 35 | $13.3M |
| Q1 2023 | 36 | $15.5M |
| Q4 2022 | 34 | $17.6M |
| Q3 2022 | 32 | $30.4M |
| Q2 2022 | 28 | $29.1M |
| Q1 2022 | 24 | $34.5M |
| Q4 2021 | 22 | $20.3M |
| Q3 2021 | 15 | $19.6M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Rani Therapeutics Holdings, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 27 | $0 | 0.00% | 00.0% | Unchanged |
| Daiwa Securities Group Inc. | 58 | $1.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 377 | $4.00K | 0.00% | −45−10.7% | Reduced |
| JPMorgan Chase & Co | 1,188 | $12.0K | 0.00% | −1,141−49.0% | Reduced |
| Tower Research Capital LLC (TRC) | 1,583 | $16.0K | 0.00% | +1,045+194.2% | Added |
| Bank of America Corp | 2,145 | $22.0K | 0.00% | −1,010−32.0% | Reduced |
| UBS Group AG | 2,538 | $26.0K | 0.00% | −1,032−28.9% | Reduced |
| Morgan Stanley | 4,098 | $43.0K | 0.00% | +820+25.0% | Added |
| The PNC Financial Services Group, Inc. | 7,416 | $77.0K | 0.00% | +7,116+2,372.0% | Added |
| Canton Hathaway, LLC | 8,600 | $89.0K | 0.03% | +8,600 | New |
| Islay Capital Management, LLC | 9,611 | $99.0K | 0.10% | +9,611 | New |
| Goldman Sachs Group Inc | 10,739 | $111.0K | 0.00% | −16,081−60.0% | Reduced |
| Northern Trust Corp | 11,430 | $118.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 12,530 | $129.0K | 0.00% | +57+0.5% | Added |
| Crossvault Capital Management LLC | 14,285 | $148.0K | 0.06% | +14,285 | New |
| Advisor Group Holdings, Inc. | 19,012 | $196.0K | 0.00% | −331−1.7% | Reduced |
| State Street Corp | 26,142 | $270.0K | 0.00% | 00.0% | Unchanged |
| Stifel Financial Corp | 42,495 | $439.0K | 0.00% | +595+1.4% | Added |
| Lasry Marc | 62,828 | $649.0K | 0.99% | 00.0% | Unchanged |
| Aspireon Wealth Advisors | 71,811 | $742.0K | 0.33% | +71,811 | New |
| Geode Capital Management, LLC | 73,449 | $758.0K | 0.00% | +2,183+3.1% | Added |
| Alpha Square Group S, LLC | 101,603 | $1.05M | 0.44% | 00.0% | Unchanged |
| Millennium Management LLC | 111,781 | $1.16M | 0.00% | +79,256+243.7% | Added |
| BlackRock Inc. | 206,832 | $2.14M | 0.00% | +49,458+31.4% | Added |
| Vanguard Group Inc | 333,129 | $3.44M | 0.00% | +43,022+14.8% | Added |
| United Services Automobile Association | 481,300 | $4.89M | 0.13% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 493,584 | $5.10M | 3.50% | 00.0% | Unchanged |
| Alphabet Inc. | 714,471 | $7.38M | 0.40% | 00.0% | Unchanged |